Report shows no-deal Brexit is still a “highly uncertain environment”
The National Audit Office report states that despite the extensive preparations, there still remains a “significant amount to do before 31 October.”
Read More
Tag: no-deal
RCGP warns new PM that we ‘cannot risk no-deal disruption’
Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.
Read More
UK ‘running out of time’ to eliminate no-deal Brexit disruption
Niall Dickson, chief executive of the NHS Confederation, expressed concerns about the plans.
Read More
No-deal Brexit could mean temporary medicines export ban
The ABPI has warned that “there a range of things outside of our control”.
Read More
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event
Sanofi has said that it could potentially airlift its flu vaccine into the UK in the event of a no-deal Brexit.
Read More
Chemistry professionals say no-deal Brexit negative for UK science
An international survey commissioned by the Royal Society of Chemistry has revealed the scale of Brexit concern in the sector across the UK, EU and beyond.
Read More
Novo Nordisk stockpiling over double usual amount ahead of Brexit
Novo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of January.
Read More
MHRA responds to consultation on Brexit no-deal proposals
In advance of the UK leaving the European Union on 29 March 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) has released a statement detailing its preparations for the event of a no-deal Brexit scenario.
Read More
Pharma calls for more detail on plan for post Brexit meds access
The pharmaceutical industry is calling on the government to urgently provide more detail on how it plans to ensure a continued supply of medicines should the UK leave the EU under a ‘no-deal’ scenario.
Read More
ABPI tells MPs Brexit deal on medicines regulation ‘urgently needed’
Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines should the UK leave the EU under a ‘no-deal’ scenario, but a deal is urgently needed to fully protect patients, MPs have been told.
Read More
MHRA consults on new regulatory framework for ‘no-deal’ scenario
The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its legislation and regulatory processes would have to be modified if the UK leaves the EU under a ‘no-deal’ scenario.
Read More
Gov’t asks drugmakers to stockpile meds for Brexit
The government has asked drug manufacturers to increase stockpiles of medicines to ensure continued supply in the event that the UK leaves the EU in a ‘no-deal’ scenario.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
